Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Renal Transplant Unit, Nephrology Department, Hospital Universitario 12 de Octubre, Barcelona, Spain. jmorales@h12o.es
Hepatitis C virus (HCV) infection is an important problem in the patient with end-stage renal disease. After transplantation, liver disease is more frequent in HCV-positive patients than in HCV-negative patients. In the long run, this leads to important liver complications. The patients have a higher risk for developing proteinuria and infections. Long-term patient and graft survival rates are lower in HCV-positive patients than in HCV-negative graft recipients. Mortality is higher, mainly as a result of liver disease and infections. Despite this, transplantation is the best option for the HCV-positive patient with end-stage renal disease. Transplantation of HCV-positive kidneys should be offered to HCV-positive recipients in whom HCV RNA is detected in the serum. Finally, several measures after transplantation minimize the consequences of HCV infection. Adjustment of immunosuppression and careful follow-up in the outpatient clinic for early detection of proteinuria, infection, or worsening of liver disease are mandatory.
Copyright 2002, Elsevier Science (USA). All rights reserved.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on